Risk of intracranial HTN w/ oral retinoids & vit A (>10,000 IU daily). Decreased absorption w/ Fe prep & antacids, Mg/Al & Ca hydroxides, oxides, salts, cholestyramine, bismuth chelates, sucralfate, quinapril; medicinal products which increase gastric pH. Decreased t
½ w/ enzyme inducers eg, barbiturates, carbamazepine, phenytoin. Increased effect of oral coumarin-type anticoagulants. May interfere w/ the bactericidal action of penicillins & β-lactam antibiotics. Reports of fatal renal toxicity w/ methoxyflurane. Increased serum levels of lithium.